Updates

GARDP Welcomes the PASTEUR Act: Recommendations for Maximizing its Public Health Impact

GARDP welcomes the re-introduction of the Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act. As a not-for-profit organization with ambitious goals to develop new treatments for drug-resistant infections that pose the greatest threat to human health, we support novel subscription models that focus on priority health needs, and which can both provide an incentive for the development of new antimicrobials and separate sales revenues from the volume of antibiotic sales. Financial models which integrate the appropriate use and stewardship of antibiotics is a critical goal for preserving the long-term effectiveness of novel antibiotics.